Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Exploring Trauma Plus (ET+) (ET+)

13 novembre 2026 aggiornato da: Envisioning Justice Solutions, Inc

Exploring Trauma Plus (ET+): A Brief Intervention for Men and Gender-Diverse Populations

This randomized controlled trial evaluates Exploring Trauma Plus (ET+), a brief, manualized, trauma-specific intervention designed for justice-involved men and transgender and gender-diverse individuals. The six-session curriculum uses psychoeducation, cognitive-behavioral strategies, mindfulness, grounding techniques, and structured exercises to help participants understand trauma, manage trauma-related distress, and develop coping skills.

The study is beging conducted at a California correctional facility for men and compares participants randomly assigned to ET+ with participants assigned to a waitlist control condition. The program is delivered by trained peer facilitators in general institutional housing on a custody level III yard.

Researchers assess changes in trauma-related distress, behavioral health symptoms, anger, and aggression using validated self-report measures administered before and after the intervention period.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The primary objective of the randomized controlled trial is to assess the effectiveness of the Exploring Trauma Plus (ET+) curriculum at reducing co-occurring trauma, anger, and aggression among men and the transgender and gender-diverse (TGD) community. Using a randomized experimental design, this study aims to quantitatively measure change on specifically targeted outcome measures over time spent in the ET+ program among a group of males and TGD individuals who participate in the program (treatment group) versus a group of similar males and TGD individuals who did not participate in the program (control group). Refined inferential statistical analyses will be employed to analyze the data collected and explore an integrated model of trajectories of trauma and aggression among participants in prison.

ET+ is a 6-week 6-session trauma-informed program that utilizes Peer Facilitators. Peer facilitators are individuals serving long-term sentences who volunteered for these positions and were specially trained to facilitate the program for other institutional residents who participate in the program.

Institutional Review Board (IRB) approval was received on May 23, 2024. CDCR Research Oversight Committee approvals and Data Sharing Agreements were sought and also approved. Oversight will continue throughout the duration of the study.

Researchers will use a randomization design to test the effectiveness of the ET+ curriculum to reduce trauma-related difficulties (i.e., mental health symptoms, trauma, anger, hostility and aggression) and to increase Restorative Justice outcome measures (i.e., resilience, social connectedness, empathy, and accountability for the harm that has been produced).

Measured outcomes will include PTSD symptoms (Trauma Symptoms Checklist [TSC-40] and the Short Screening Scale for DSM-IV PTSD), depression (Patient Health Questionnaire - Depression Subscale), anxiety (Patient Health Questionnaire - Anxiety), aggression (Buss-Warren Aggression Questionnaire), mental health functioning (K6 Brief Mental Health Screen), instrumental and expressive anger (Revised Instrumental and Expressive Representation Scales), the Brief Resilient Coping Scale, and the Dickman Impulsivity Scale.

Tipo di studio

Interventistico

Iscrizione (Stimato)

250

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • California
      • Corcoran, California, Stati Uniti, 93212
        • Reclutamento
        • California State Prison, Corcoran
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria: All participants who expressed interest in participating in the study at the California men's prison and who were capable of providing written informed consent.

-

Exclusion Criteria: There were no study-defined exclusion criteria; operational exclusions or security restrictions were at the discretion of prison administration.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Exploring Trauma Plus Brief Intervention

This revised evidence-based six-session trauma intervention is designed for people who have experienced abuse and trauma. The understanding of gender has shifted from the binary male-female model to a more inclusive and expansive model. This second edition of Exploring Trauma is now entitled Exploring Trauma+: A Brief Intervention for Men and Gender-Diverse People in order to reflect the changes in this new edition. The definition of gender responsiveness has been expanded to include the experiences of transgender and nonbinary people. This new material has inclusive pronouns, as well as examples of traumatic events and focus questions specific to this group. The materials focus on the three core things that both staff and clients need: an understanding of what trauma is, its process, and its impact on both the inner self (thoughts, feelings, beliefs, values) and the outer self (behavior and relationships).

ET+ is an evidence-based 6-session brief intervention with a focus on trauma and PTSD, and techniques for Restorative Justice work with men (and those who identify as men). The rigorously evaluated manualized curriculum is designed for trauma treatment while emphasizing Restorative Justice principles and objectives, e.g., understanding victim impact, personal accountability, and restitution. The intervention is delivered to small groups of 10-12 men and co-led by two specially trained Peer Facilitators. Using a closed group model creates the experience of a prosocial support system based on a new value system and group agreements. This is strengthened by using Peer Facilitators as role models. The group process helps develop empathy and connectedness for other group members.

Nessun intervento: Waitlist Control Group

Participants assigned to the waitlist control condition, serving as the comparison group during the study. Participants are offered Exploring Trauma Plus (ET+) after their study participation.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Modified Short Screening Scale for DSM-IV PTSD (7-item symptom index, following a trauma-exposure screen)
Lasso di tempo: Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.

The Modified Short Screening Scale for DSM-IV PTSD is a 7-item measure assessing the frequency of posttraumatic stress symptoms following exposure to a traumatic event. Items assess symptom frequency over the preceding four weeks, with responses ranging from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.
Patient Health Questionnaire (PHQ) Anxiety Subscale
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Patient Health Questionnaire (PHQ) Anxiety Subscale is a 7-item measure assessing the frequency of anxiety symptoms over the preceding four weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). The total score range is 0-18, with higher scores indicating greater anxiety symptom frequency.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
PHQ-9 Depression Subscale
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Patient Health Questionnaire-9 (PHQ-9) is a 9-item measure assessing the frequency of depressive symptoms over the preceding two weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 composite score.
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Trauma Symptom Checklist-40 (TSC-40) is a 40-item measure assessing trauma-related symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). The composite score ranges from 0 to 120, with higher scores indicating greater trauma-related distress.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Anxiety Subscale
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Anxiety subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related anxiety symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater anxiety symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Depression Subscale
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Depression subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related depressive symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater depressive symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
TSC-40 Outcome Measures 1. Dissociation Subscale
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Dissociation subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 6 items assessing dissociative symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater dissociative symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Outcome Measures 2. Sexual Abuse Trauma Index (SATI)
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Sexual Abuse Trauma Index (SATI) of the TSC-40 consists of 7 items assessing symptoms associated with sexual abuse trauma over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Outcome Measures 3. Sleep Disturbances Subscale
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Sleep Disturbances subscale of the TSC-40 consists of 6 items assessing sleep-related difficulties over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater sleep disturbance.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
Buss-Warren Aggression Questionnaire (AQ)
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

A measure of aggressive behavior and tendencies. ET+ uses only the Verbal Aggression and Physical Aggression subscales to assess verbal and physical expressions of aggression.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
Brief Resilient Coping Scale
Lasso di tempo: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

A 4-item measure assessing the ability to cope with stress in an adaptive and resilient manner.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Investigatore principale: NENA P Messina, Envisioning Justice Solutions, Inc

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 aprile 2026

Completamento primario (Stimato)

30 giugno 2028

Completamento dello studio (Stimato)

30 giugno 2028

Date di iscrizione allo studio

Primo inviato

13 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

13 novembre 2026

Primo Inserito (Effettivo)

18 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • EJS-ETP-RCT-02
  • C5613014 (Altro numero di sovvenzione/finanziamento: THE CALIFORNIA DEPARTMENT OF CORRECTIONS AND REHABILITATION (CDCR) - INNOVATIVE PROGRAMMING GRANT)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared because sharing is subject to applicable data-use restrictions and authorization from the California Department of Corrections and Rehabilitation (CDCR).

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .